Abstract:Background: Gastric antral vascular ectasia (GAVE) has diverse associations and presumed causes, which include liver cirrhosis, chronic kidney disease, and autoimmune disease. This heterogeneity of underlying disorders suggests that the pathogenesis of GAVE may be variable. Aim: To compare the clinical features and long-term outcomes of GAVE according to endoscopic patterns and etiologies. Methods: The medical records and endoscopic images of 23 consecutive patients diagnosed with GAVE by endoscopy at Yeungnam University Hospital from January 2006 to December 2020 were retrospectively reviewed. Patients were allocated to cirrhosis (16 patients) and non-cirrhosis groups (7 patients). GAVE subtypes, as determined by endoscopy, were categorized as punctate (a diffuse, honeycomb-like appearance, 17 patients) or striped (a linear, watermelon-like appearance, 6 patients). Results: All GAVE patients with cirrhosis (16/16, 100%) had a punctate pattern by endoscopy, whereas the majority of patients (6/7, 85.7%) without cirrhosis had a striped pattern (P < 0.001). Overt GAVE bleeding (10/23, 43%) was significantly more common in the non-cirrhosis group than in the cirrhosis group (6/7, 85.7% vs 4/16, 25.0%; P = 0.019), and more common in the striped group than in the punctate group (5/6, 83.3% vs 5/17, 29.4%; P = 0.052). However, mean numbers of admissions due to GAVE bleeding and argon plasma coagulation (APC) sessions to address overt bleeding were similar in the cirrhosis and non-cirrhosis groups and in the punctate and striped groups. All patients with GAVE bleeding were successfully treated by APC, and no patient died from GAVE-related blood loss during a median follow-up of 24 mo. Conclusion: Punctate-type GAVE is strongly associated with liver cirrhosis, and GAVE patients without cirrhosis tend to be more prone to overt bleeding. However, the presence of cirrhosis and endoscopic patterns did not influence long-term clinical courses or outcomes in cases of overt bleeding.

[Gastric antral vascular ectasia:clinical presentation and therapeutic management]

Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques

Recurrent gastric antral vascular ectasia: a single center experience

Gastric Antral Vascular Ectasia: the Evolution of Therapeutic Modalities

Gastric antral vascular ectasia (Watermelon stomach); an unusual cause of upper gastrointestinal bleeding in elderly: A case report

Endoscopic treatment for gastric antral vascular ectasia

Upper gastrointestinal bleeding from gastric antral vascular ectasia following cocaine use: case presentation and review of literature

Anemia Secondary to Gastric Antral Vascular Ectasia Successfully Treated With Antral Gastrectomy

Successful Surgical Management of Gastric Antral Vascular Ectasia in a Patient with End-Stage Renal Disease: A Case Report and Literature Review

Gastric Antral Vascular Ectasia: Resolution of Bleeding and Stabilization of Hematocrit Following Orthotopic Liver Transplantation

Repeated endoscopic treatment of gastric antral vascular ectasia

Influences of etiology and endoscopic appearance on the long-term outcomes of gastric antral vascular ectasia

S1888 Clinical Relevance and Implications of Gastric Antral Vascular Ectasia (GAVE) in Cirrhotic Patients

Comparing Endoscopic Treatment Modalities for Gastric Antral Vascular Ectasia: Efficacy, Safety, and Outcomes in a Network Meta-analysis

Diagnosis of gastric antral vascular ectasia by transnasal flexible spectral imaging color enhancement

Resolution of gastric antral vascular ectasia following cessation of imatinib

A case of gastric antral vascular ectasia in which PuraStat, a novel self‐assembling peptide hemostatic hydrogel, was effective

Role of Endoscopy in the Diagnosis, Grading, and Treatment of Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia

The misclassification of gastric antral vascular ectasia

The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology

S2340 Effect of PPI Therapy on EGD-Free Interval in Patients With Gastric Antral Vascular Ectasia